FI905912A - Förfarande för framställning av farmaceutiskt användbara 6-(1-hydroxietyl)-3-(substituerad tio)-7-oxo-1-azabicyklo/3.2.0/hept-2-en-2-karboxylsyraderivat - Google Patents
Förfarande för framställning av farmaceutiskt användbara 6-(1-hydroxietyl)-3-(substituerad tio)-7-oxo-1-azabicyklo/3.2.0/hept-2-en-2-karboxylsyraderivat Download PDFInfo
- Publication number
- FI905912A FI905912A FI905912A FI905912A FI905912A FI 905912 A FI905912 A FI 905912A FI 905912 A FI905912 A FI 905912A FI 905912 A FI905912 A FI 905912A FI 905912 A FI905912 A FI 905912A
- Authority
- FI
- Finland
- Prior art keywords
- azabicyclo
- hept
- oxo
- hydroxyethyl
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44601789A | 1989-12-04 | 1989-12-04 | |
US44601789 | 1989-12-04 | ||
US61392190A | 1990-11-20 | 1990-11-20 | |
US61392190 | 1990-11-20 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI905912A0 FI905912A0 (sv) | 1990-11-30 |
FI905912A true FI905912A (sv) | 1991-06-05 |
FI96311B FI96311B (sv) | 1996-02-29 |
FI96311C FI96311C (sv) | 1996-06-10 |
Family
ID=27034476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI905912A FI96311C (sv) | 1989-12-04 | 1990-11-30 | Förfarande för framställning av farmaceutiskt användbara 6-(1-hydroxietyl)-3-(substituerad tio)-7-oxo-1-azabicyklo/3.2.0/hept-2-en-2-karboxylsyraderivat |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0433759A1 (sv) |
KR (1) | KR910011856A (sv) |
AU (2) | AU643735B2 (sv) |
CA (1) | CA2031487A1 (sv) |
FI (1) | FI96311C (sv) |
HU (1) | HU213265B (sv) |
IE (1) | IE904348A1 (sv) |
IL (1) | IL96528A (sv) |
NO (1) | NO177640C (sv) |
NZ (1) | NZ236319A (sv) |
OA (1) | OA09333A (sv) |
PT (1) | PT96080B (sv) |
YU (1) | YU229290A (sv) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5672701A (en) * | 1990-01-16 | 1997-09-30 | Bristol-Myers Squibb Company | 4-substituted alkyl carbapenem antibiotics |
US5317016A (en) * | 1991-08-20 | 1994-05-31 | Shionogi Seiyaku Kabushiki Kaisha | Pyrrolidylthiocarbapenem derivative |
NO20015844L (no) | 2001-11-30 | 2003-06-02 | Arne Kristiansen | Anordning for å produsere et trykkpotensial over et legeme |
PL2710007T3 (pl) | 2011-05-17 | 2020-06-01 | The Regents Of The University Of California | Inhibitory kinazy |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4312871A (en) * | 1979-12-03 | 1982-01-26 | Merck & Co., Inc. | 6-, 1- And 2-substituted-1-carbadethiapen-2-em-3-carboxylic acids |
JPS60202886A (ja) * | 1984-03-27 | 1985-10-14 | Sankyo Co Ltd | 1―置換カルバペネム―3―カルボン酸誘導体 |
CA1272719A (en) * | 1986-03-06 | 1990-08-14 | Pierre Dextraze | Carbapenem antibiotics |
US4960879A (en) * | 1988-03-23 | 1990-10-02 | Shionogi & Co., Ltd. | Process for carbapenem intermediates |
US5189158A (en) * | 1991-03-20 | 1993-02-23 | American Cyanamid Company | 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them |
-
1990
- 1990-11-30 FI FI905912A patent/FI96311C/sv not_active IP Right Cessation
- 1990-12-03 NO NO905215A patent/NO177640C/no unknown
- 1990-12-03 NZ NZ236319A patent/NZ236319A/en unknown
- 1990-12-03 KR KR1019900019777A patent/KR910011856A/ko not_active Application Discontinuation
- 1990-12-03 IE IE434890A patent/IE904348A1/en unknown
- 1990-12-04 OA OA59911A patent/OA09333A/xx unknown
- 1990-12-04 IL IL9652890A patent/IL96528A/en not_active IP Right Cessation
- 1990-12-04 AU AU67688/90A patent/AU643735B2/en not_active Ceased
- 1990-12-04 YU YU229290A patent/YU229290A/sh unknown
- 1990-12-04 CA CA002031487A patent/CA2031487A1/en not_active Abandoned
- 1990-12-04 EP EP90123258A patent/EP0433759A1/en not_active Withdrawn
- 1990-12-04 PT PT96080A patent/PT96080B/pt not_active IP Right Cessation
- 1990-12-04 HU HU908046A patent/HU213265B/hu not_active IP Right Cessation
-
1993
- 1993-09-03 AU AU46117/93A patent/AU661192B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
HUT56371A (en) | 1991-08-28 |
NO905215D0 (no) | 1990-12-03 |
AU4611793A (en) | 1993-12-02 |
AU661192B2 (en) | 1995-07-13 |
AU643735B2 (en) | 1993-11-25 |
IL96528A (en) | 1996-06-18 |
OA09333A (fr) | 1992-09-15 |
HU213265B (en) | 1997-04-28 |
PT96080B (pt) | 1998-02-27 |
YU229290A (sh) | 1993-05-28 |
AU6768890A (en) | 1991-06-06 |
PT96080A (pt) | 1991-09-30 |
EP0433759A1 (en) | 1991-06-26 |
KR910011856A (ko) | 1991-08-07 |
FI96311C (sv) | 1996-06-10 |
FI96311B (sv) | 1996-02-29 |
NO177640C (no) | 1995-10-25 |
NO177640B (no) | 1995-07-17 |
FI905912A0 (sv) | 1990-11-30 |
HU908046D0 (en) | 1991-06-28 |
NO905215L (no) | 1991-06-05 |
IE904348A1 (en) | 1991-06-05 |
NZ236319A (en) | 1994-02-25 |
CA2031487A1 (en) | 1991-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI880941A0 (sv) | Förfarande för framställning av terapeutiskt användbara piperazinyl-heterocykliska föreningar | |
FI890282A (sv) | Förfarande för framställning av terapeutiskt användbara 23,24-didehydro-25-hydroxikalciferolderivat | |
FI883064A (sv) | Förfarande för framställning av terapeutiskt användbara heterocykliska föreningar | |
FI982790A (sv) | Förfarande för framställning av klavulansyra | |
FI910860A0 (sv) | Förfarande för framställning av som läkemedel användbara /2-(1-homopiperazinkarbonyl)pyrrolidin-4-yltio/-6-(1-hydroxietyl)-1-karbapen-2-em-3-karboxylatsalt | |
FI880467A (sv) | Förfarande för framställning av terapeutiskt användbara substituerade 3,4-dihydro-2H-benzopyraner | |
FI981709A0 (sv) | Förfarande för framställning av 5-substituerade 2-amino-4-oxo-pyrrolo/2,3-d/-pyrimidiner | |
FI93215C (sv) | Förfarande för framställning av terapeutiskt användbara aminoalkoxifenylderivat | |
FI104075B1 (sv) | Förfarande för framställning av terapeutiskt användbara 2-karboxitienylkarbamoylpyrrolidin-4-ylkarbapenem-3-karboxylsyraderivat | |
FI873350A (sv) | Förfarande för framställning av terapeutiskt användbara 1,4-dihydropyridinderivat | |
NO175976C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater | |
FI103727B1 (sv) | Förfarande för framställning av terapeutiskt användbara 2-amino-4-substituerad-fenyl-4H-pyrano[3,2-h]kinolin-3-karbonitriler | |
FI893003A0 (sv) | Förfarande för framställning av terapeutiskt användbara neplanocinderivat | |
FI884660A0 (sv) | Förfarande för framställning av terapeutiskt aktiva 2,2-dimetylkromenderivat | |
FI92202B (sv) | Förfarande för framställning av nya terapeutiskt användbara 4-substituerade pyrazolo/3,4-d/pyrimidinderivat | |
FI900145A0 (sv) | Förfarande för framställning av farmaceutiskt användbara 1,1-dioxo-cefem-4-karbotiolsyraderivat | |
FI905912A (sv) | Förfarande för framställning av farmaceutiskt användbara 6-(1-hydroxietyl)-3-(substituerad tio)-7-oxo-1-azabicyklo/3.2.0/hept-2-en-2-karboxylsyraderivat | |
FI92188C (sv) | Förfarande för framställning av terapeutiskt användbara fenoxialkylpyrokatekolderivat | |
FI906084A0 (sv) | Förfarande för framställning av nya terapeutiskt användbara 5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)indolderivat | |
FI943833A (sv) | Förfarande för framställning av 2,3,5,6-tetraklorpyridin | |
FI93216C (sv) | Analogiförfarande för framställning av terapeutiskt användbara 1,3-dioxanalkensyraderivat | |
FI893121A (sv) | Förfarande för framställning av terapeutiskt aktiva 6,21-dimetyl-19-norprogestronderivat | |
FI893250A0 (sv) | Förfarande för framställning av nya terapeutiskt användbara 1,4-diazepinderivat | |
FI912247A (sv) | Förfarande för framställning av terapeutiskt användbara pyrrolo/2,3-b/indolketonderivat | |
FI885033A0 (sv) | Förfarande för framställning av 1,5-bensotiazepinderivat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
MM | Patent lapsed | ||
MM | Patent lapsed |
Owner name: BRISTOL-MYERS SQUIBB COMPANY |